Hint of Benefit Seen With Blood Pressure Medicine in Steady-PD3 Trial
A re-examination of blood samples from people with early Parkinson’s disease in a Phase 3 trial — in which…
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A re-examination of blood samples from people with early Parkinson’s disease in a Phase 3 trial — in which…
Alterations in gut microorganisms found in the appendix of people with Parkinson’s disease…
An extract from three plant species reduced signs of motor disturbances in rodent models of…
People with Parkinson’s disease with symptoms affecting one side of the body, who were treated with focused…
Later age at Parkinson’s disease onset is associated with high adherence to the MIND…
A smartphone application designed to measure and monitor the walking mobility of people with Parkinson’s disease captured a…
Treatment with the antioxidant metal-alloy nanozyme reduced the build-up (aggregation) and transmission of disease-causing alpha-synuclein protein in the…
Changes in how brainwaves synchronize, known to occur in people with Parkinson’s disease,…
Visual hallucinations in people with Parkinson’s disease are associated with a thinning of…
Production of the protein TOM20 rescued nerve cells that are damaged in people with Parkinson’s…
Get regular updates to your inbox.